Peter P. Pfreundschuh is EVP, CFO and Treasurer of Y-mAbs Therapeutics, Inc.. Currently has a direct ownership of 0 shares of YMAB, which is worth approximately $0. The most recent transaction as insider was on Sep 16, 2025, when has been sold 77,800 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

PETER P. PFREUNDSCHUH Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 16 2025
SELL
Sale (or disposition) back to the issuer
-
77,800 Reduced 100.0%
0 Common Stock
Jan 17 2025
BUY
Grant, award, or other acquisition
-
31,800 Added 29.01%
77,800 Common Stock
Jul 12 2024
BUY
Grant, award, or other acquisition
-
46,000 Added 50.0%
46,000 Common Stock

Also insider at

URGN
UroGen Pharma Ltd. Healthcare
FREQ
Frequency Therapeutics, Inc. Healthcare
VYGR
Voyager Therapeutics, Inc. Healthcare
PPP

Peter P. Pfreundschuh

EVP, CFO and Treasurer
Cambridge, MA

Track Institutional and Insider Activities on YMAB

Follow Y-mAbs Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells YMAB shares.

Notify only if

Insider Trading

Get notified when an Y M Abs Therapeutics, Inc. insider buys or sells YMAB shares.

Notify only if

News

Receive news related to Y-mAbs Therapeutics, Inc.

Track Activities on YMAB